Quellen
- 1
Vaquerizo .
et al..
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.
Thorax.
2003;
58
204-210
- 2
Price DB.
et al..
Clinical Observation of Montelukast as a Partner Agent for Complementary Therapy.
Thorax.
2003;
58
211-216
- 3
Bjermer L.
et al..
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting
against asthma exacerbation in adults: one year, double blind, randomised, comparative
trial;.
BMJ.
2003;
327
891-813
- 4
Philip .
et al..
The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal
allergic rhinitis.
Curr Med Res Opin..
2004;
20
1549-1558
- 5
Pacor ML.
et al..
Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind,
placebocontrolled comparison of treatment with montelukast and ceterizine in patients
with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid.
Clin Exp Allergy .
2001;
31
1607-1614
- 6 Symposium "Der Stellenwert der Leukotriene in der Allergologie - Synergieeffekte
mit neuen therapeutischen Konzepten", September 2004 in Aachen, Veranstalter: MSD
SHARP & DOHME GMBH.
01 SINGULAIR® 10 mg, MSD SHARP & DOHME, Haar
